Management of chronic total occlusion by percutaneous coronary intervention

Heart

Volumn 98, Issue 10, 2012, Pages 822-828

  Hoye, Angela ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYPHER; RAPAMYCIN; UNCLASSIFIED DRUG;

ANGINA PECTORIS; ANGIOCARDIOGRAPHY; BALLOON; BARE METAL STENT; CARDIOVASCULAR EQUIPMENT; CATHETER; CHRONIC TOTAL OCCLUSION; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY CALCIFICATION; CORONARY ARTERY COLLATERAL CIRCULATION; CORONARY ARTERY DISEASE; DRUG ELUTING STENT; EXERCISE TOLERANCE; GUIDE WIRE; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HEART TAMPONADE; HUMAN; INTRAVASCULAR ULTRASOUND; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LONG TERM SURVIVAL; MORTALITY; PATIENT ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PERFORATION; PRIORITY JOURNAL; QUALITY OF LIFE; RESTENOSIS; REVIEW; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANGIOPLASTY, BALLOON, CORONARY; CHRONIC DISEASE; CORONARY OCCLUSION; DIAGNOSTIC IMAGING; HUMANS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84860912394     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2011-300616     Document Type: Review

References (20)

1. Christofferson RD, Lehmann KG, Martin GV, et al. Effect of chronic total coronary occlusion on treatment strategy. Am J Cardiol 2005;95:1088-91. A large registry demonstrating that CTOs are found commonly in patients with significant coronary disease and that the presence of a CTO affects future management, with fewer patients referred for percutaneous revascularisation, and the majority managed with either medical therapy or referred for coronary bypass graft surgery. (Pubitemid 40544315)
2. Puma JA, Sketch MH Jr, Tcheng JE, et al. Percutaneous revascularization of chronic coronary occlusions: an overview. J Am Coll Cardiol 1995;26:1-11. Review of the benefits of successful percutaneous revascularisation of CTOs in leading to improved quality of life and a reduced need for coronary bypass surgery.
3. Suero JA, Marso SP, Jones PG, et al. Procedural outcomes and long-term survival among patients undergoing percutaneous coronary intervention of a chronic total occlusion in native coronary arteries: a 20-year experience. J Am Coll Cardiol 2001;38:409-14. The first large registry to demonstrate that successful CTO PCI is associated with an improved long term survival compared with patients with unsuccessful CTO PCI. (Pubitemid 32721768)
4. Valenti R, Migliorini A, Signorini U, et al. Impact of complete revascularization with percutaneous coronary intervention on survival in patients with at least one chronic total occlusion. Eur Heart J 2008;29:2336-42.
5. Claessen BE, van der Schaaf RJ, Verouden NJ, et al. Evaluation of the effect of a concurrent chronic total occlusion on long-term mortality and left ventricular function in patients after primary percutaneous coronary intervention. JACC Cardiovasc Interv 2009;2:1128-34. Registry demonstrating that the presence of a concurrent CTO is associated with a significantly higher mortality rate in patients undergoing primary PCI for acute myocardial infarction.
6. Rahel BM, Laarman GJ, Kelder JC, et al. Three-year clinical outcome after primary stenting of totally occluded native coronary arteries: a randomized comparison of bare-metal stent implantation with sirolimus-eluting stent implantation for the treatment of total coronary occlusions (Primary Stenting of Totally Occluded Native Coronary Arteries [PRISON] II study). Am Heart J 2009;157:149-55. The only randomised study to show that drug eluting (Cypher) stents are superior to bare metal stents for the treatment of CTOs, with a reduction in restenosis and need for target vessel revascularisation.
7. Colmenarez HJ, Escaned J, Fernandez C, et al. Efficacy and safety of drug-eluting stents in chronic total coronary occlusion recanalization: a systematic review and meta-analysis. J Am Coll Cardiol 2010;55:1854-66.
8. Saeed B, Kandzari DE, Agostoni P, et al. Use of drug-eluting stents for chronic total occlusions: a systematic review and meta-analysis. Catheter Cardiovasc Interv 2011;77:315-32.
9. Wijns W, Kolh P, Danchin N, et al; The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic surgery (EACTS). Guidelines on myocardial revascularization. Eur Heart J 2010;31:2501-55.
10. Patel MR, Dehmer GJ, Hirshfeld JW, et al. ACCF/SCAI/STS/ AATS/AHA/ASNC 2009 Appropriateness Criteria for coronary revascularization: a report by the American College of Cardiology Foundation Appropriateness Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, and the American Society of Nuclear Cardiology. Endorsed by the American Society of Echocardiography, the Heart Failure Society of America, and the Society of Cardiovascular Computed Tomography. J Am Coll Cardiol 2009;53:530-53.
11. Rathore S, Matsuo H, Terashima M, et al. Procedural and inhospital outcomes after percutaneous coronary intervention for chronic total occlusions of coronary arteries 2002 to 2008: impact of novel guidewire techniques. JACC Cardiovasc Interv 2009;2:489-97. Registry of the (relatively low) procedural adverse event rate when expert operators perform CTO angioplasty in contemporary practice.
12. Mollet NR, Hoye A, Lemos PA, et al. Value of preprocedure multislice computed tomographic coronary angiography to predict the outcome of percutaneous recanalization of chronic total occlusions. Am J Cardiol 2005;95:240-3. (Pubitemid 40092090)
13. Ehara M, Terashima M, Kawai M, et al. Impact of multislice computed tomography to estimate difficulty in wire crossing in percutaneous coronary intervention for chronic total occlusion. J Invasive Cardiol 2009;21:575-82.
14. British Cardiovascular Intervention Society. BCIS Audit Returns 2008. http://www.BCIS.org.uk
15. Di Mario C, Werner GS, Sianos G. European perspective in the recanalisation of chronic total occlusions (CTO): consensus document from the EuroCTO Club. Eurointervention 2007;3:30-43. Consensus document from CTO PCI experts, outlining the European perspective and recommending that only interventionists with a specific interest in CTOs should be performing complex CTO PCI.
16. Thompson CA, Jayne JE, Robb JF, et al. Retrograde techniques and the impact of operator volume on percutaneous intervention for coronary chronic total occlusions: an early U.S. experience. JACC Cardiovasc Interv 2009;2:834-42. Important study demonstrating that adoption of specialist CTO techniques (by operators with an interest in CTO PCI) is associated with a significantly improved rate of successful recanalisation.
17. Surmely JF, Tsuchikane E, Katoh O, et al. New concept for CTO recanalization using controlled antegrade and retrograde subintimal tracking: the CART technique. J Invasive Cardiol 2006;18:334-8. First publication that describes using the retrograde approach to facilitate successful CTO recanalisation. (Pubitemid 44014134)
18. Galassi AR, Costanzo L, Tomasello SD, et al. Right coronary artery chronic total occlusion revascularization by knuckle technique through right gastroepiploic artery graft. Clin Res Cardiol 2010;99:587-90.
19. Rathore S, Terashima M, Suzuki T. Value of intravascular ultrasound in the management of coronary chronic total occlusions. Catheter Cardiovasc Interv 2009;74:873-8.
20. Prasad A, Rihal CS, Lennon RJ, et al. Trends in outcomes after percutaneous coronary intervention for chronic total occlusions: a 25-year experience from the Mayo Clinic. J Am Coll Cardiol 2007;49:1611-18. CTO angioplasty has previously been associated with concerns regarding procedural mortality. This large registry demonstrates that, over time, there has been a significant reduction in mortality, with no deaths in recent practice. (Pubitemid 46551620)